Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Baxter
Harvard Business School
McKesson
Merck

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Caprylic acid

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Caprylic acid?

Caprylic acid is an investigational drug.

There have been 5 clinical trials for Caprylic acid. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2017.

The most common disease conditions in clinical trials are Peripheral Nervous System Diseases, Diabetic Neuropathies, and Tremor. The leading clinical trial sponsors are Accera, Inc., Celerion, and University of British Columbia.

There are nine hundred and twenty-five US patents protecting this investigational drug and ten international patents.

Recent Clinical Trials for Caprylic acid
TitleSponsorPhase
Topical Menthol +/- Mannitol for Painful Diabetic Peripheral NeuropathyUniversity of British ColumbiaPhase 1/Phase 2
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body ProductionCelerionPhase 1
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body ProductionAccera, Inc.Phase 1

See all Caprylic acid clinical trials

Clinical Trial Summary for Caprylic acid

Top disease conditions for Caprylic acid
Top clinical trial sponsors for Caprylic acid

See all Caprylic acid clinical trials

US Patents for Caprylic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Caprylic acid   Start Trial Substituted thiohydantoin derivatives as androgen receptor antagonists Janssen Pharmaceutica NV (Beerse, BE)   Start Trial
Caprylic acid   Start Trial Preparation of poly alpha-1,3-glucan esters and films therefrom E I DU PONT DE NEMOURS AND COMPANY (Wilmington, DE)   Start Trial
Caprylic acid   Start Trial Underlayer film-forming composition for self-assembled films NISSAN CHEMICAL INDUSTRIES, LTD. (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Colorcon
Boehringer Ingelheim
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.